| Year |
Citation |
Score |
| 2009 |
Rossol-Allison J, Stemmle LN, Swenson-Fields KI, Kelly P, Fields PE, McCall SJ, Casey PJ, Fields TA. Rho GTPase activity modulates Wnt3a/beta-catenin signaling. Cellular Signalling. 21: 1559-68. PMID 19482078 DOI: 10.1016/J.Cellsig.2009.05.010 |
0.459 |
|
| 2009 |
Suzuki H, Kimura K, Shirai H, Eguchi K, Higuchi S, Hinoki A, Ishimaru K, Brailoiu E, Dhanasekaran DN, Stemmle LN, Fields TA, Frank GD, Autieri MV, Eguchi S. Endothelial nitric oxide synthase inhibits G12/13 and rho-kinase activated by the angiotensin II type-1 receptor: implication in vascular migration. Arteriosclerosis, Thrombosis, and Vascular Biology. 29: 217-24. PMID 19095998 DOI: 10.1161/Atvbaha.108.181024 |
0.415 |
|
| 2009 |
Suzuki H, Motley ED, Eguchi K, Hinoki A, Shirai H, Watts V, Stemmle LN, Fields TA, Eguchi S. Distinct roles of protease-activated receptors in signal transduction regulation of endothelial nitric oxide synthase. Hypertension. 53: 182-8. PMID 19064814 DOI: 10.1161/Hypertensionaha.108.125229 |
0.393 |
|
| 2006 |
Stemmle LN, Fields TA, Casey PJ. The regulator of G protein signaling domain of axin selectively interacts with Galpha12 but not Galpha13. Molecular Pharmacology. 70: 1461-8. PMID 16868183 DOI: 10.1124/Mol.106.023705 |
0.563 |
|
| 2006 |
Kelly P, Stemmle LN, Madden JF, Fields TA, Daaka Y, Casey PJ. A role for the G12 family of heterotrimeric G proteins in prostate cancer invasion. The Journal of Biological Chemistry. 281: 26483-90. PMID 16787920 DOI: 10.1074/Jbc.M604376200 |
0.515 |
|
| 2005 |
Meigs TE, Juneja J, DeMarco CT, Stemmle LN, Kaplan DD, Casey PJ. Selective uncoupling of G alpha 12 from Rho-mediated signaling. The Journal of Biological Chemistry. 280: 18049-55. PMID 15746095 DOI: 10.1074/Jbc.M500445200 |
0.581 |
|
| Show low-probability matches. |